These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 75005)

  • 41. In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.
    Hanke AA; Maschler S; Schöchl H; Flöricke F; Görlinger K; Zanger K; Kienbaum P
    Scand J Trauma Resusc Emerg Med; 2011 Feb; 19():12. PubMed ID: 21310047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
    Boldt J; Mengistu A
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dextran and haemostasis. A review.
    Bergqvist D
    Acta Chir Scand; 1982; 148(8):633-40. PubMed ID: 6189321
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro effects of three formulations of hydroxyethyl starch solutions on coagulation and platelet function in horses.
    Blong AE; Epstein KL; Brainard BM
    Am J Vet Res; 2013 May; 74(5):712-20. PubMed ID: 23627384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):71-8. PubMed ID: 19527967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of hydroxyethyl starch on blood coagulation profile.
    Türkan H; Ural AU; Beyan C; Yalçin A
    Eur J Anaesthesiol; 1999 Mar; 16(3):156-9. PubMed ID: 10225163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch.
    Dorner I; Moore JA; Collins JA; Sherman LA; Chaplin H
    Transfusion; 1975; 15(5):439-48. PubMed ID: 53916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged plasma clotting time and decreased fibrinolysis after long term treatment with alpha-tocopherol.
    Korsan-Bengtsen K; Elmfeldt D; Holm T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):505-12. PubMed ID: 4422949
    [No Abstract]   [Full Text] [Related]  

  • 50. [The effect of low-molecular hydroxyethyl starch and dextran 60 on the muscle oxygen supply in intensive care patients].
    Kopp KH; Kieser M; Sinagowitz E; Lund N
    Infusionsther Klin Ernahr; 1982 Feb; 9(1):44-51. PubMed ID: 6176540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function.
    Sossdorf M; Marx S; Schaarschmidt B; Otto GP; Claus RA; Reinhart K; Hartog CS; Lösche W
    Crit Care; 2009; 13(6):R208. PubMed ID: 20028511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The metabolism of organ cultures of cornea in TC 199 with added dextran 500 or hydroxyethyl starch 450].
    Reim M; Hesse R; Pietruschka G
    Klin Monbl Augenheilkd; 1990 Feb; 196(2):76-80. PubMed ID: 1691324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro effect of hydroxyethyl starch 130/0.42 on canine platelet function.
    Classen J; Adamik KN; Weber K; Rubenbauer S; Hartmann K
    Am J Vet Res; 2012 Dec; 73(12):1908-12. PubMed ID: 23176416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The influence of different plasma substitutes on blood clotting in isovolaemic haemodilution (author's transl)].
    Martin E; Armbruster I; Fischer E; Kraatz J; Kersting KH; Oberst R; Peter K
    Anaesthesist; 1976 Apr; 25(4):181-4. PubMed ID: 58563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of abnormal fibrinolytic activity, blood coagulation factors and platelet function in high-altitude pulmonary oedema with frusemide.
    Singh I; Chohan IS
    Int J Biometeorol; 1973 Mar; 17(1):73-81. PubMed ID: 4753836
    [No Abstract]   [Full Text] [Related]  

  • 57. Hydroxyethyl starch as a substitute for dextran 40 for thawing peripheral blood progenitor cell products.
    Zhu F; Heditke S; Kurtzberg J; Waters-Pick B; Hari P; Margolis DA; Keever-Taylor CA
    Cytotherapy; 2015 Dec; 17(12):1813-9. PubMed ID: 26454752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antishock blood substitute based on hydroxyethyl starch].
    Polushina TV; Prostakova TM; Bogino NA
    Probl Gematol Pereliv Krovi; 1980 Mar; 25(3):40-4. PubMed ID: 6154296
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of artificial colloids on haemostasis.
    Jin SL; Yu BW
    Br J Hosp Med (Lond); 2009 Feb; 70(2):101-3. PubMed ID: 19229151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dextran and hydroxyethyl starch interfere with fibrinogen assays.
    Hiippala ST
    Blood Coagul Fibrinolysis; 1995 Dec; 6(8):743-6. PubMed ID: 8825225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.